CIRM Funded Clinical Trials

Autologous ARTEMISĀ® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer

Disease Area:
CIRM Grant:
CLIN2-14338 (Active)
Award Value:
Trial Sponsor:
Eureka Therapeutics, Inc.
Trial Stage:
Phase 1/2
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website